Frederick Davidorf, MD

Frederick H. Davidorf, MD, is an emeritus professor of ophthalmology at The Ohio State University, specializing in vitreoretinal surgery and ophthalmic oncology, with a focus on uveal melanoma, eye melanoma, and other ocular malignancies such as malignant neoplasms of the eye. He treats patients with proliferative diabetic retinopathy, vitreous hemorrhage, and solid tumors of the eye and orbit, often participating in clinical trials like intravitreal ranibizumab for diabetic retinopathy and MRI